2 Amendments of Lynn BOYLAN related to 2017/2951(RSP)
Amendment 40 #
Paragraph 8
8. Recalls the importance of the Clinical Trials Regulation in stimulating and facilitating research into new vaccinations and ensuring transparency of results of clinical trials; calls on the Commission and the European Medicines Agency to implement the Clinical Trials Regulation without further delay; in particular through setting up the European Portal and Database (EUPD) whose implementation has seen significant delays of over two years;
Amendment 41 #
Paragraph 8 – subparagraph 1 (new)
Further calls upon all parties involved to ensure that the current process of relocating the EMA away from London does not cause any additional disruption or delays to the work of the Agency;